secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tyra Biosciences, Inc. (TYRA)
CIK:        0001863127
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001193125-23-159845
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tyra Biosciences stockholders elect three Class II directors, ratify E&Y as auditor
--------------------------------------------------------------------------------

- Stockholders elected Isan Chen (37.3M for), Gilla Kaplan (37.6M for), and Robert More (37.6M for) as Class II directors to serve until 2026.
- Ratification of Ernst & Young as independent auditor for FY 2023 passed with 40,984,756 for, 625 against, and 1,819 abstentions.
- Broker non-votes were 3,109,065 for director elections and 0 for auditor ratification.
- Annual meeting held on May 31, 2023; all proposals approved by substantial majorities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1863127/000119312523159845/0001193125-23-159845-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1863127/000119312523159845/d509793d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-159845

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer